{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:16:10Z","timestamp":1791209770962,"version":"4.1.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2019.01007","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T13:44:48Z","timestamp":1571406288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways"],"prefix":"10.3389","volume":"10","author":[{"given":"Mohamed Diwan M.","family":"AbdulHameed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat R.","family":"Pannala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wallqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1186\/s12864-016-3143-y","article-title":"Mining kidney toxicogenomic data by using gene co-expression modules","volume":"17","author":"AbdulHameed","year":"2016","journal-title":"BMC Genomics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"112193","DOI":"10.1371\/journal.pone.0112193","article-title":"Systems level analysis and identification of pathways and networks associated with liver fibrosis","volume":"9","author":"AbdulHameed","year":"2014","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0192623314549960","article-title":"Identification of environmental chemicals associated with the development of toxicant-associated fatty liver disease in rodents","volume":"43","author":"Al-Eryani","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1124\/pr.108.00001","article-title":"Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis","volume":"60","author":"Anderson","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/toxsci\/kfw018","article-title":"Tipping the balance: hepatotoxicity and the 4 apical key events of hepatic steatosis","volume":"150","author":"Angrish","year":"2016","journal-title":"Toxicol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00204-014-1197-7","article-title":"A simple transcriptomic signature able to predict drug-induced hepatic steatosis","volume":"88","author":"Benet","year":"2014","journal-title":"Arch. Toxicol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.14573\/altex.2012.4.411","article-title":"The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans","volume":"29","author":"Blaauboer","year":"2012","journal-title":"ALTEX"},{"key":"B12","doi-asserted-by":"publisher","first-page":"14250","DOI":"10.1038\/ncomms14250","article-title":"Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions","volume":"8","author":"Blais","year":"2017","journal-title":"Nat. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.febslet.2004.07.055","article-title":"Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments","volume":"573","author":"Breitling","year":"2004","journal-title":"FEBS Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.1158\/0008-5472.CAN-09-1482","article-title":"Overactivation of the MEK\/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4","volume":"69","author":"Caja","year":"2009","journal-title":"Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/JOM.0b013e31822cfd68","article-title":"Serum cytokeratin 18 and cytokine elevations suggest a high prevalence of occupational liver disease in highly exposed elastomer\/polymer workers","volume":"53","author":"Cave","year":"2011","journal-title":"J. Occup. Environ. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/hep.23321","article-title":"Toxicant-associated steatohepatitis in vinyl chloride workers","volume":"51","author":"Cave","year":"2010","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"key":"B18","doi-asserted-by":"publisher","first-page":"46658","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1194\/jlr.M001602","article-title":"FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats","volume":"51","author":"Cipriani","year":"2010","journal-title":"J. Lipid Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.redox.2015.07.005","article-title":"Role of NADPH oxidases in the redox biology of liver fibrosis","volume":"6","author":"Crosas-Molist","year":"2015","journal-title":"Redox Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1158\/1078-0432.CCR-10-1126","article-title":"A 4-gene signature associated with clinical outcome in high-grade gliomas","volume":"17","author":"de Tayrac","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1093\/bioinformatics\/btx292","article-title":"RankProd 2.0: a refactored bioconductor package for detecting differentially expressed features in molecular profiling datasets","volume":"33","author":"Del Carratore","year":"2017","journal-title":"Bioinformatics"},{"key":"B23","first-page":"505","article-title":"Expression of fatty acid synthase in nonalcoholic fatty liver disease","volume":"3","author":"Dorn","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/etc.4453","article-title":"Linking mitochondrial dysfunction to organismal and population health in the context of environmental pollutants: progress and considerations for mitochondrial adverse outcome pathways","volume":"38","author":"Dreier","year":"2019","journal-title":"Environ. Toxicol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat. Protoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1021\/acs.jcim.8b00297","article-title":"QSAR Modeling of ToxCast Assays Relevant to the Molecular Initiating Events of AOPs Leading to Hepatic Steatosis","volume":"58","author":"Gadaleta","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.12.036","article-title":"Genetic liver-specific AMPK activation protects against diet-induced obesity and NAFLD","author":"Garcia","year":"2019","journal-title":"Cell. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2013analysis of Affymetrix genechip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"B29","article-title":"Genefilter: methods for filtering genes from high-throughput experiments. R package version 1.64.0","author":"Gentleman","year":"2018"},{"key":"B30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"93046","DOI":"10.1371\/journal.pone.0093046","article-title":"A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers","volume":"9","author":"Goonesekere","year":"2014","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11432","DOI":"10.1038\/srep11432","article-title":"TRRUST: a reference database of human transcriptional regulatory interactions","volume":"5","author":"Han","year":"2015","journal-title":"Sci. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"D921","DOI":"10.1093\/nar\/gku955","article-title":"Open TG-GATEs: a large-scale toxicogenomics database","volume":"43","author":"Igarashi","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/1091581812466418","article-title":"Putative mechanisms of environmental chemical-induced steatosis","volume":"31","author":"Kaiser","year":"2012","journal-title":"Int. J. Toxicol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/bioinformatics\/btn647","article-title":"arrayQualityMetrics\u2013a bioconductor package for quality assessment of microarray data","volume":"25","author":"Kauffmann","year":"2009","journal-title":"Bioinformatics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.abb.2010.09.001","article-title":"Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport","volume":"504","author":"Kawano","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"B39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/toxsci\/kfn237","article-title":"Parallelogram approach using rat-human in vitro and rat in vivo toxicogenomics predicts acetaminophen-induced hepatotoxicity in humans","volume":"107","author":"Kienhuis","year":"2009","journal-title":"Toxicol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10408444.2018.1429386","article-title":"Non-animal methods to predict skin sensitization (II): an assessment of defined approaches","volume":"48","author":"Kleinstreuer","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.bbadis.2014.02.004","article-title":"FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model","volume":"1842","author":"Kunne","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"B42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.gastro.2010.03.033","article-title":"A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis","volume":"139","author":"Lee","year":"2010","journal-title":"Gastroenterology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/carcin\/bgy081","article-title":"The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro","volume":"39","author":"Mascolo","year":"2018","journal-title":"Carcinogenesis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/0192623317747549","article-title":"Comparative proteomic analysis of liver steatosis and fibrosis after oral hepatotoxicant administration in sprague-dawley rats","volume":"46","author":"McDyre","year":"2018","journal-title":"Toxicol. Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J. Hepatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/10408444.2015.1089471","article-title":"The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways","volume":"46","author":"Mellor","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"9488","DOI":"10.3748\/wjg.v22.i43.9488","article-title":"Nonalcoholic fatty liver disease - A multisystem disease","volume":"22","author":"Mikolasevic","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s40572-016-0079-y","article-title":"Accelerating adverse outcome pathway development using publicly available data sources","volume":"3","author":"Oki","year":"2016","journal-title":"Curr. Environ. Health Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"54825","DOI":"10.1371\/journal.pone.0054825","article-title":"Effect of fasting on the metabolic response of liver to experimental burn injury","volume":"8","author":"Orman","year":"2013","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"11678","DOI":"10.1038\/s41598-018-30149-7","article-title":"Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat","volume":"8","author":"Pannala","year":"2018","journal-title":"Sci. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"0205747","DOI":"10.1371\/journal.pone.0205747","article-title":"Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease","volume":"13","author":"Pettinelli","year":"2018","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/toxsci\/kfw026","article-title":"Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium","volume":"151","author":"Ryan","year":"2016","journal-title":"Toxicol. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"114085","DOI":"10.1371\/journal.pone.0114085","article-title":"Whole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcome","volume":"9","author":"Sahini","year":"2014","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1478-3231.2010.02346.x","article-title":"Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease","volume":"31","author":"Schwingel","year":"2011","journal-title":"Liver Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11033-010-0140-0","article-title":"Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase","volume":"38","author":"Shen","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2012.11.010","article-title":"Aldehyde dehydrogenases in cellular responses to oxidative\/electrophilic stress","volume":"56","author":"Singh","year":"2013","journal-title":"Free Radic. Biol. Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1289\/ehp.95103386","article-title":"Molecular and cellular approaches to extrapolation for risk assessment","volume":"103","author":"Sutter","year":"1995","journal-title":"Environ. Health Perspect."},{"key":"B61","doi-asserted-by":"publisher","first-page":"86795","DOI":"10.1371\/journal.pone.0086795","article-title":"Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices","volume":"9","author":"Szalowska","year":"2014","journal-title":"PLoS ONE"},{"key":"B62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.3748\/wjg.v20.i26.8393","article-title":"Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease","volume":"20","author":"Toshikuni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1179\/1351000213Y.0000000050","article-title":"The relationship between oxidative stress and nonalcoholic fatty liver disease: its effects on the development of nonalcoholic steatohepatitis","volume":"18","author":"Ucar","year":"2013","journal-title":"Redox Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tox.2013.08.011","article-title":"The adverse outcome pathway concept: a pragmatic tool in toxicology","volume":"312","author":"Vinken","year":"2013","journal-title":"Toxicology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00204-014-1211-0","article-title":"Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models","volume":"88","author":"Vitins","year":"2014","journal-title":"Arch. Toxicol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tox.2017.07.020","article-title":"The use of high-throughput screening techniques to evaluate mitochondrial toxicity","volume":"391","author":"Wills","year":"2017","journal-title":"Toxicology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0378-4274(00)00218-6","article-title":"The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity","volume":"116","author":"Wong","year":"2000","journal-title":"Toxicol. Lett."},{"key":"B69","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hep.26698","article-title":"Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B72","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2019.01007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T13:44:52Z","timestamp":1571406292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2019.01007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":72,"alternative-id":["10.3389\/fgene.2019.01007"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2019.01007","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]},"article-number":"1007"}}